Arcadia Biosciences announces USD 4 million at-the-market private placement of 3,883,496 shares priced at USD 1.03 each

Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc.

RKDA

0.00
  • Arcadia Biosciences priced a USD 4 million at-the-market private placement under Nasdaq rules at USD 1.03 per share.
  • Investors to buy 3,883,496 common shares or pre-funded warrants, bundled with Series A-1 and Series A-2 preferred investment options.
  • Both option series carry a USD 0.91 exercise price; A-1 expires five years post stockholder approval, A-2 expires 24 months post resale registration.
  • Deal expected to close June 12; H.C. Wainwright serving as exclusive placement agent.
  • Proceeds earmarked for working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief on June 11, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.